Immunotherapy

Immunotherapy is the concept of using the immune system to treat disease, for example, developing a vaccine against cancer. Immunotherapy may also refer to the therapy of diseases caused by the immune system, allergies for example.

What is Immunotherapy?

Immunotherapy is a treatment that is designed to harness the ability of the body’s immune system to combat infection or disease.

Immunotherapy and Helminthic Therapy

Suppression Immunotherapies

Adoptive T Cell Therapy Methodology

Activation Immunotherapies

Immunotherapy: Past, Present and Future

Neoantigens' Role in Immunotherapy

Adoptive T Cell Therapy Applications

Immunotherapy: The Future of Lung Cancer Treatment?

Latest Immunotherapy News and Research

New surgical approaches aim to improve stomach cancer outcomes

Sometimes innovation in cancer care means developing something entirely new. Other times, it means returning to an old idea with the knowledge and tools to make it work better.

12 Nov 2026

Unusual allergy triggers cause anaphylaxis in children and teenagers

When people think about anaphylaxis, peanuts, shellfish, or even bee sting often come to mind. Three medically challenging cases presented at the American College of Allergy, Asthma and Immunology (ACAAI) 2026 Annual Scientific Meeting show that severe allergic reactions can come from far less obvious places: a fish ingredient hidden in an energy drink, a natural hair oil and a popular children's sensory toy.

12 Nov 2026

Clinicians continue ordering food allergy panels despite false positive risks

New research being presented at the 2026 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) showed many clinicians in a survey knew that food allergy panel testing often results in false positives- yet they kept ordering it anyway.

12 Nov 2026

Experimental vaccines aim to treat and prevent aggressive cancers

For more than three decades, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center researchers have pursued an ambitious idea: that vaccines could train the immune system to recognize and fight cancer.

12 Nov 2026

Biologic drug offers promising protection against alpha-gal syndrome

The summer of 2026 was a particularly bad season for ticks. And with it came a rising number of cases of alpha-gal syndrome (AGS) thanks to bites from the Lone Star Tick.

12 Nov 2026

Stocking epinephrine in schools protects students and eases family financial burdens

For school kids with severe food allergies, having epinephrine on hand at school can mean the difference between a scary moment and a life-threatening one.

12 Nov 2026

Language barriers delay early peanut introduction for many infants

Feeding peanut products to infants early in life is one of the best tools doctors have to help prevent peanut allergy.

12 Nov 2026

Study reveals frequent insurance denials for pediatric biologic allergy treatments

When a child's severe asthma, eczema, hives, or food allergy isn't under control, an allergist may prescribe a newer type of medicine called a biologic.

12 Nov 2026

Biologic drug for eosinophilic esophagitis lowers childhood asthma risk

Young children treated for eosinophilic esophagitis (EoE) with dupilumab (a biologic medication) were less likely to develop asthma in the future compared with children who received a different treatment.

12 Nov 2026

New salt-triggered gel makes bacterial cancer therapy much safer

The abdominal cavity is salty enough to set a gel. On that trick rests a delivery system reported in The Innovation: a small molecule that stays liquid in the syringe and, meeting sodium in the peritoneum, gels within a minute.

12 Nov 2026

Experimental drug targets tumor barriers to unlock cancer-killing T cells

Many solid tumors, including many cancers of the pancreas, breast, brain and lung, protect themselves with a dense wall of scar-like tissue.

11 Nov 2026

Can psychedelics help treat cancer beyond easing end-of-life fear?

A new peer-reviewed review in Psychedelics opens on a strange fact, gathered from existing laboratory studies rather than new experiments: a brain tumor can learn to eavesdrop.

11 Nov 2026

EU-funded project develops mRNA vaccine targeting liver cancer

The European Innovation Council (EIC) is providing approximately €3.8 million in funding for the international research project ADVANCE, in which Universitätsmedizin Frankfurt is participating. The ADVANCE research team aims to develop an mRNA-based cancer vaccine for the treatment of hepatocellular carcinoma (HCC).

10 Nov 2026

Mayo Clinic research advances treatment options for genitourinary cancers

Cancers of the reproductive and urinary organs, known as genitourinary cancers, affect millions of people worldwide each year. Yousef Zakharia, M.D., a Mayo Clinic medical oncologist, leads clinical research aimed at improving treatment results for patients with kidney, bladder and prostate cancers.

10 Nov 2026

New treatment approach could help people with muscle-invasive bladder cancer live longer

A new treatment approach could help people with an aggressive form of bladder cancer live longer and reduce the chances of their cancer returning or progressing, particularly those who cannot receive standard chemotherapy, according to findings from a large international clinical trial co-led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center.

9 Nov 2026

Blocking complement factor B halts pancreatic cancer growth

Researchers have identified a promising new target in the treatment of pancreatic cancer. A new study in The American Journal of Pathology, published by Elsevier, demonstrates that blocking complement factor B (CFB), a pivotal enzyme in the alternative complement pathway, halts cancer growth and alters the tumor microenvironment.

9 Nov 2026